Alimera Sciences, Inc. (ALIM) Financials
ALIM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 153.5 million | 107.4 million |
2023-09-30 | 154.2 million | 105.4 million |
2023-06-30 | 154.9 million | 108.7 million |
2023-03-31 | 48.2 million | 67.2 million |
ALIM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 3.7 million | 805000 |
2023-09-30 | -9.8 million | 188000 |
2023-06-30 | -81.4 million | 216000 |
2023-03-31 | -2.2 million | 226000 |
ALIM Net Income
No data available :(
ALIM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 12.1 million | - | 828000 |
2023-09-30 | 8.3 million | - | 193000 |
2023-06-30 | 18.8 million | 64.0 million | 203000 |
2023-03-31 | 13.1 million | - | 263000 |
ALIM Shares Outstanding
ALIM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 85000 | 4.8 million | 6.4 million | 7.8 million |
2023-09-30 | 4000 | 4.0 million | 3.6 million | 7.9 million |
2023-06-30 | 75.4 million | 3.6 million | 4.4 million | 6.4 million |
2023-03-31 | 9000 | 4.2 million | 4.2 million | 5.8 million |
ALIM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 26.3 million | 6.7 million |
2023-09-30 | 23.4 million | 2.8 million |
2023-06-30 | 17.5 million | 2.4 million |
2023-03-31 | 13.5 million | 2.0 million |
ALIM
Price: $3.65
52 week price:
Earnings Per Share: -0.84 USD
P/E Ratio: -2.36
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 7882
Ebitda: -3.1 millionMarket Capitalization: 191.2 million